BEVERLY FOWLER: Open Payments
NPI 1831798552 · CAIRO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $254 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $241 |
| Amgen Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Exact Sciences Corporation | 1 | $90 |
| Sumitomo Pharma America, Inc. | 1 | $79 |
Products named: OTEZLA, Biktarvy, AIRSUPRA, Epclusa, Cologuard Collection Kit, GEMTESA.
Industry payments across GA — which companies pay providers there.
